References
- Karandikar N J, Hotchkiss E C, Mckenna R W, Kroft S H. Transient stress lymphocytosis: an immunophenotypic characterization of the most common causes of newly identified adult lymphocytosis in a tertiary hospital. Am J Clin Pathol 2002; 117: 819–825
- Juneja S, Januszewicz E, Wolf M, Cooper I. Post-splenectomy lymphocytosis. Clin Lab Haematol 1995; 17: 335–337
- Scott C S, Richards S J, Sivakumaran M, Short M, Child J A, Hunt K M, et al. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: the Yorkshire leukaemia group study. Br J Haematol 1993; 83: 504–515
- Sala P, Tonutti E, Feruglio C, Florian F, Colombatti A. Persistent expansions of CD4+ CD8+ peripheral blood T-cells. Blood 1993; 2: 1546–1552
- Okuno S H, Tefferi A, Hanson C A, Katzmann J A, Li C, Witzig T E. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol 1996; 93: 810–812
- International Society Laboratory Hematology. Consensus guidelines: rules, http://www.islh.org/2007/index.php?page=consensus_rules. Accessed 27 February, 2007.
- Marti G E, Rawstron A C, Ghia P, Hillmen P, Houlston R S, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332
- Rawstron A C, Green M J, Kusmicki A, Fenton J A, Evans P A, O'Connor S J, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 35–639
- Rachel J M, Zucker M L, Fox C M, Plapp F V, Menitove J E, Abbasi F, et al. Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol 2007; 139: 832–836
- Marti G E, Abasi F, Raveche E, Rawstron A C, Ghia P, Aurran T. Overview of monoclonal B-cell lymphocytosis. Br J Haematol 2007; 139: 701–708
- Ghia P, Prato G, Scielzo C, Geuna M, Caligaris-Cappio F. Monoclonal CD5+ and CD5-B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337–2342
- Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, Rai K R. National cancer institute – sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
- Jack A, Richards S, Evans P, Wilks C. Population screening for B-cell monoclonal lymphocytosis using pcr and flow cytometry to determine immunophenotypes. Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders. Georgia, Atlanta 1997; 93–96
- Molica S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991; 78: 895–899
- D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, et al. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol 2007; 82: 787–791
- Calin G A, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik S E, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801
- Hamblin T J, Orchard J A, Ibbotson R E, Davis Z, Thomas P W, Stevenson F K, Oscier D G. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023–1029
- Cao T M, Coutre S E. Management of advanced chronic lymphocytic leukemia. Curr Hematol Rep 2003; 2: 65–72
- Auer R L, Gribben J, Cotter F E. Emerging therapy for chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 635–644
- Rawstron A C. Monoclonal B-cell lymphocytosis: good news for patients and CLL investigators. Leuk Lymphoma 2007; 48: 1057–1058